Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SIS | Ann: Becoming a substantial holder - Balmain | 09:31 | 8 | 1.8K | |||
|
|||||||
SIS | Ann: At Call Funding Facility Capital Raise | 03/03/24 | 4 | 1.4K | |||
|
|||||||
SIS | Ann: Placement Completion, Board and Executive Changes | 26/02/24 | 20 | 5.5K | |||
|
|||||||
SIS | Ann: Cleansing Notice | 26/02/24 | 0 | 161 | |||
|
|||||||
SIS | Ann: Application for quotation of securities - SIS | 26/02/24 | 0 | 143 | |||
|
|||||||
SIS | Ann: Initial Director's Interest Notice - Wang | 21/02/24 | 0 | 220 | |||
|
|||||||
SIS | News: SIS Simble Solutions Says Ben Loiterton Resigns As Executive Chairman | 21/02/24 | 0 | 142 | |||
|
|||||||
SIS | Ann: Appendix 4E Preliminary Financial Report FY2023 | 21/02/24 | 0 | 190 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |